|

Decision making in the therapeutic jungle of aHCC: a Changing Treatment Dynamic

Welcome

{{ getTitle(live) }}

{{ toDate(live.liveStartDate) }}

{{ toTime(live.liveStartDate) }} - {{ toTime(live.liveEndDate) }}


{{ getNotification(live) }}

Expert guidance on systemic aHCC treatment choices tailored to your patient's needs.

 

PROGRAMME:

  • HCC landscape and new data
  • Certainties & uncertainties in HCC
  • Case 1: NASH (elderly, frail patient)
  • Case 2: AtezoBev followed by second line
  • Case 3: Transplant patient
  • Closing: Glimpse of the future

 

 

 

Speakers

Prof. Chris Verslype

Prof. Chris Verslype

UZ Leuven

Prof. Ivan Borbath

Prof. Ivan Borbath

UCL Saint Luc

Expert guidance on systemic aHCC treatment choices tailored to your patient's needs.

 

PROGRAMME:

  • HCC landscape and new data
  • Certainties & uncertainties in HCC
  • Case 1: NASH (elderly, frail patient)
  • Case 2: AtezoBev followed by second line
  • Case 3: Transplant patient
  • Closing: Glimpse of the future